MCM
ZBH icon

MAI Capital Management’s Zimmer Biomet ZBH Stock Holding History

MAI Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,339
Closed -$131K – 576
2020
Q1 		$131K Buy
+1,339
New +$176K 0.01% 509

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MAI Capital Management's ZBH Position: Q1 2026 in Review

MAI Capital Management reduced its Zimmer Biomet (ZBH) stake by 3.8% in Q1 2026, selling an estimated $9.18K and leaving 2,550 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #1392.

MAI Capital Management first reported a position in ZBH in Q1 2020 and has held it in 25 quarters since. The position peaked at $605K in Q2 2021. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • MAI Capital Management held 2,550 shares of Zimmer Biomet worth $231K as of Q1 2026.
  • MAI Capital Management sold 100 Zimmer Biomet shares in Q1 2026, an estimated $9.18K.
  • Zimmer Biomet made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #1392 holding.
  • MAI Capital Management first reported a position in Zimmer Biomet in Q1 2020 and has held it in 25 quarters since.
  • MAI Capital Management's Zimmer Biomet position peaked at $605K in Q2 2021.
  • 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.